OptiNose, Inc. (NASDAQ:OPTN) Q2 2021 Earnings Conference Call August 11, 2021 11:00 AM ET Company Participants Jonathan Neely - VP, IR & Business Operations Peter Miller - CEO & Director Keith Goldan - CFO Ramy Mahmoud - President & COO Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. Steve Daddeo - RBC Capital Markets Kenneth Cacciatore - Cowen and Company David Amsellem - Piper Sandler & Co. Operator Good morning, ladies and gentlemen, and welcome to the OptiNose Second Quarter 2021 E ...

Building a Leading ENT / Allergy Specialty Company Corporate Presentation August 11, 2021 This presentation and our accompanying remarks contain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements that are not historical facts are hereby identified as forward-looking statements for this purpose and include, among others, statements relating to: potential for continued XHANCE prescription and net revenue growth and factors supporting su ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ______________. Commission file number: 001-38241 OPTINOSE, INC. (Exact name of registrant as specified in its charter) (State of other jurisdictio ...

| --- | --- | --- | --- | |-------|-------------------|----------------------------------|-------| | | | | | | | Specialty Company | Building a Leading ENT / Allergy | | | | | Corporate Presentation | | | | | May 5, 2021 | | Forward-Looking Statements This presentation and our accompanying remarks contain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements that are not historical facts are hereby identified as forward-looking statement ...

OptiNose, Inc. (NASDAQ:OPTN) Q1 2021 Earnings Conference Call May 5, 2021 8:00 AM ET Company Participants Jonathan Neely - VP, IR & Business Operations Keith Goldan - Chief Financial Officer Peter Miller - Chief Executive Officer Ramy Mahmoud - President and Chief Operating Officer Victor Clavelli - Chief Commercial Officer Conference Call Participants Gary Nachman - BMO Capital Markets Georgi Yordanov - Cowen and Company Ed Chung - Jefferies Brandon Folkes - Cantor Fitzgerald Daniel Busby - RBC Capital Ma ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to ______________. Commission file number: 001-38241 OPTINOSE, INC. (Exact name of registrant as specified in its charter) (State of other jurisdicti ...

OptiNose, Inc. (NASDAQ:OPTN) Q4 2020 Earnings Conference Call March 3, 2021 8:00 AM ET Company Participants Jonathan Neely – Vice President-Investor Relations Peter Miller – Chief Executive Officer Keith Goldan – Chief Financial Officer Ramy Mahmoud – President and Chief Operating Officer Vic Clavelli – Chief Commercial Officer Conference Call Participants Steve Daddeo – RBC Capital Markets Gary Nachman – BMO Capital Markets Brandon Folkes – Cantor Fitzgerald David Amsellem – Piper Sandler Georgi Yordanov – ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2020 OR ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from ___________ to ______________. Commission file number: 001-38241 OPTINOSE, INC. (Exact name of registrant as specified in its charter) (State of other jurisdiction of incorpo ...

OptiNose, Inc. (NASDAQ:OPTN) Q3 2020 Results Conference Call November 5, 2020 8:00 AM ET Company Participants Jonathan Neely - Vice President, Investor Relations Peter Miller - Chief Executive Officer Ramy Mahmoud - President and Chief Operating Officer Vic Clavelli - Chief Commercial Officer Keith Goldan - Chief Financial Officer Conference Call Participants Stacy Ku - Cowen David Steinberg - Jefferies Brandon Folkes - Cantor Fitzgerald Rafay Sardar - BMO Operator Ladies and gentlemen, thank you for standi ...

| --- | --- | --- | |-------|-----------------------------------------------------|-------| | | | | | | Building a Leading ENT / Allergy Specialty Company | | | | Corporate Presentation | | | | November 5, 2020 | | Forward-Looking Statements This presentation and our accompanying remarks contain "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements that are not historical facts are hereby identified as forward-looking statements for this ...